Drug Database
Back to search

Belgium· BE-AMP-SAM135536-00

Victan 2 mg

A ethyl loflazepate product containing ethyl loflazepate, registered in Belgium by Neuraxpharm Belgium. The same ATC class is registered in 2 of our 19 countries.

ATC N05BA18

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVictan 2 mgATCN05BA18REGISTER NO.BE-AMP-SAM135536-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethyl loflazepateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethyl loflazepate is registered in 2 of 19 countries.

Countries holding a registration under ATC N05BA18 (ethyl loflazepate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose
Search ethyl loflazepate products by name

Ethyl loflazepate · ATC N05BA18

2 / 19 countries

  • Belgiumprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ethyl Loflazepate
Manufacturer
Neuraxpharm Belgium
Country
Belgium (BE)
ATC code
N05BA18
ATC class
Ethyl loflazepate
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0601005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethyl loflazepate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethyl loflazepate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • France · Victan
  • Luxembourg · Victan
  • Portugal · Victan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/841eeaf8-fb06-417b-8574-ff4279660df3
GET /v1/drugs/841eeaf8-fb06-417b-8574-ff4279660df3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Victan 2 mg",
  "name_fr": "Victan 2 mg",
  "name_nl": "Victan 2 mg",
  "amp_code": "SAM135536-00",
  "strengths": [
    "2.0000",
    "2.0000",
    "0.0150",
    "65.0000",
    "6.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Ethyl Loflazepate",
    "E 110",
    "Lactose",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ethyl Loflazepate",
  "authorisation_numbers": [
    "BE135536"
  ]
}
API referenceMCP serverPlans

See everything about ethyl loflazepate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console